AsclepiX Therapeutics Company
![](/storage/logos_100px/AsclepiX Therapeutics.jpg)
AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
Baltimore, Maryland, United States
Founded Date:
2011
Employees Number:
11-50
Funding Status:
Early Stage Venture
Estimated Revenue:
Less than $1M
Register and Claim Ownership